McKesson posted adjusted earnings per share of $8.03 for the quarter ended December 31, 2024, missing the analyst consensus of $8.27. Revenue came in at $95.29 billion, up 18% YoY but below the ...

McKesson Corporation (NYSE:MCK) Q3 2025 Earnings Call Transcript February 5, 2025 Operator: Welcome to McKesson’s Third Quarter Fiscal 2025 Earnings Conference Call. Please be advised that today ...

McKesson's minimal exposure to US-Mexico-Canada tariffs and geopolitical tensions ensures stability. Read why MCK stock is a ...

McKesson beat earnings expectations with an adjusted EPS of $8.03, coming in just ahead of the projected $8.01. Revenue for Q3 came in at $95.3 billion, falling slightly short of the estimated $96 ...

IRVING, Texas (AP) — IRVING, Texas (AP) — McKesson Corp. (MCK) on Wednesday reported fiscal third-quarter earnings of $879 million. The Irving, Texas-based company said it had profit of $6.95 per ...

McKesson management provided guidance for FY 2025, expecting earnings between $32.55 and $32.95 per share. To track all earnings releases for McKesson visit their earnings calendar here.

McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and ...

McKesson (MCK) closed the most recent trading day at $660.86, moving -0.05% from the previous trading session. This change lagged the S&P 500's daily gain of 1.77%. Elsewhere, the Dow saw an ...

For the quarter ended December 2024, McKesson (MCK) reported revenue of $95.29 billion, up 17.8% over the same period last year. EPS came in at $8.03, compared to $7.74 in the year-ago quarter.

Source: Analyst estimates for the quarter provided by FactSet. McKesson operates in the , providing distribution and logistics services for pharmaceuticals, medical supplies, and technology solutions.